Dr. Volker Geiss, DVM is an experienced toxicologic pathologist and toxicologist with about 30 years of experience in preclinical safety and drug development. He is currently working as an independent expert consultant to Pharma and Biotech.
Volker built a successful career at Bayer AG taking roles of increasing responsibility to become Head of Experimental Toxicology. He has broad experience with Health Authority interactions and has been instrumental in helping to define the toxicology and regulatory strategy of many pre-clinical programs at Entry-into-Human and clinical programs seeking Marketing Authorization.
Volker has worked across a range of different indications but has significant depth of expertise with cardiovascular drugs with successful approvals of Xarelto® and Adempas®.
Volker is a Doctor of Veterinary Medicine with a Specialization in Veterinary Pathology from The University of Giessen, Germany.